Navigation Links
DNA Medicine Institute Awarded NIH Grant for Emergency Point-of-Care Blood Sensor
Date:3/9/2010

CAMBRIDGE, Mass., March 9 /PRNewswire/ -- The DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).  The grant is designed to shrink technology found in large hospital hematology analyzers, typically the size of small refrigerators, to a tiny, palm-sized device.  The emergency blood sensor is designed to make these tests readily available under any scenario and easily performed by minimally trained personnel.  Applicable settings include hospitals, emergency rooms, physicians' offices, ambulances, global health clinics, and remote field locations.  The Institute envisions this technology will be integrated into its Universal Blood Sensor platform, which is designed to perform all hospital tests on a handheld, point-of-care device.

"We are pleased that the NIH is supporting our efforts to develop a potentially transformative human diagnostics platform.  The NHLBI understands the human impact of a point-of-care blood sensor that can diagnose acute blood loss, sepsis, and other critical health conditions," said Eugene Y. Chan, M.D., President and Chief Scientific Officer of the DNA Medicine Institute.  "This funding will allow us to further innovations in the point-of-care diagnostics field and speed development of a technology that can be utilized to make a difference for those in need."

About DNA Medicine Institute

The DNA Medicine Institute is a commercial organization whose mission is to advance patient care, alleviate human suffering, and treat disease through innovation.  Founded by Eugene Y. Chan, M.D., its core beliefs are that successful, innovative commercial products can make a long-lasting impact on patient care.  It currently does research on intuitive medical devices, smartly designed drugs, and powerful research instrumentation.  One of these is the Universal Blood Sensor, a technology designed to perform a full health analysis of a person, anywhere, anytime, and with a single drop of blood.  The DNA Medicine Institute's multi-faceted approach to innovation draws upon diverse fields including medicine, nanotechnology, genomics, biophysics, biochemistry, molecular biology, and advanced engineering.  For more information, visit:  www.dnamedinstitute.com.

SOURCE DNA Medicine Institute

Back to top

RELATED LINKS
http://www.dnamedinstitute.com

'/>"/>

SOURCE DNA Medicine Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Chronically Ill Patients Find Help Paying For Medicines
2. Missouri Becomes the Fourth State to Connect to Kentuckys Real-time Cold Medicine Tracking System
3. Partnership for a Drug-Free Americas 21st Annual Teen Survey Shows No Significant Increase in Over-the-Counter Medicine Abuse Rates
4. IVF FLORIDA Reproductive Associates Partners with The University of Miami School of Medicine and Jackson Memorial Health
5. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
6. GSK Statement on FDAs Proposed Label Revisions for Some Asthma Medicines
7. Americas Biopharmaceutical Companies Studying 183 New Medicines to Counter Diabetes Growth
8. Johns Hopkins Medicine Acquires Naviscan PEM Technology for Novel Radiotracer Research
9. Dutch Public-Private Partnership Invests 28 Million Euro on Research Into Personalized Medicine
10. The Womens Heart Foundation Presents the Womens Heart Advocate Award for Medicine and Science to Multifunction CardioGram(TM) Inventor Dr. Joseph T. Shen
11. The American Academy of Pain Medicine Announces this Years Presidential Commendations and Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):